IJGC

This is our family. The #IJGCfamily 🌍💜 We are people from all over the world who have formed friendships and collaborations despite being separated by thousands of miles. No matter what language we speak, we always understand each other. No matter the time difference, we are always there for each other. 🕰️🤝 Our family has grown by creating branches and interconnections, guided by Pedro Ramirez @pedroramirezMD, our mentor, and guide over the years.🏆 Thank you to all the members of this great family for making IJGC what it is today. @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 @RParejaGineOnco

✨ Don’t miss our next #IJGCclub! 🗓️ April 15 | 8:00 am CDT / 3:00 pm CEST 📖 Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic with Rene Pareja @RParejaGineOnco 🔗 Don’t miss this engaging discussion: bit.ly/4jfSMEP @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

Los tratamientos tópicos para el VPH se promocionan cada vez más—pero la evidencia sigue siendo fundamentalmente insuficiente: • Ningún ECA ha demostrado reducción en NIC2+ • Se utilizan desenlaces sustitutos como si fueran beneficio clínico • Ensayos con bajo poder, diseños deficientes y alta heterogeneidad • Seguimiento insuficiente para la historia natural del VPH • Ausencia de plausibilidad biológica y oncológica en muchos casos Esto no es innovación—es una traducción prematura de evidencia débil. La observación sigue siendo el estándar de cuidado ante infección por PVH(Sin importar genotipo) y LIE de bajo grado @aepccolposcopia @ESGO_society @IPVSociety @IGCSociety @IJGConline @IJGCfellows

Topical treatments for HPV are increasingly promoted—but the evidence remains fundamentally insufficient: • No RCT has demonstrated reduction in CIN2+ • Surrogate endpoints are misused as clinical benefit • Trials are underpowered, poorly designed, and heterogeneous • Follow-up is inadequate for HPV natural history • No credible biologic or oncologic rationale in many cases This is not innovation—it is premature translation of weak evidence. Observation remains the standard of care in HPV infection(despite genotype and LSIL @IGCSociety @ESGO_society @aepccolposcopia @IPVSociety @SGO_org @IJGCfellows

#WorldofHopeWednesdays 🌍💙 Cervical cancer is largely preventable, yet it continues to affect women worldwide. Through collaboration, training, and education, IGCS programs supported by World of Hope contribute to global efforts toward cervical cancer elimination. Be part of the movement. 🔗 igcs.org/donate

From glycemic control to normothermia 🌡️ This article explores the #ERAS hot topics 🔥 shaping more practical, patient-centered peri-operative care in gynecologic surgery 🏥✨ #ERASWorldCongress 💡 bit.ly/4veeNtC @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

Topical therapies for high-risk HPV: promising—but where’s the evidence? 🤔 This editorial highlights a key gap in current practice 🚫 ❌ No randomized trials show reduced progression to CIN2+ ⚠️ HPV clearance does NOT equal cancer prevention 📌 Observation remains the standard of care A timely reminder: innovation must be backed by robust evidence before clinical adoption. 🔗 bit.ly/4t9s7xW @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration sciencedirect.com/science/articl… Comprehensive genomic 🧬 profiling has transitioned into routine oncology practice, enabling precision medicine through identification of actionable mutations. Tissue-agnostic therapies, supported by regulatory approvals and innovative trial designs, allow treatment across tumor types sharing molecular features. Frameworks like ESCAT guide clinical decision-making. Despite progress, challenges such as tumor heterogeneity, regulatory hurdles, and access disparities persist, limiting widespread and equitable implementation of precision oncology in clinical care. @ChiaraCrem1 @oncologiaroma @DottBotticelliA @p_ciracimd @VStudiale @pashtoonkasi @CathyEngMD @marklewismd @manjuggm @ARosen380 @KoheiShitara @GillSharlene @BenWestphalen #OncoAlertAF @nataliagandur @acampsmalea @FernandoOnco @ElisaAgostinett @to_be_elizabeth @realbowtiedoc @Lucarecco @GaiaGriguolo @JankovicK @MarioBalsaMD @Onco_Cifu88 @matteolambe @aftimosp @E_de_Azambuja @Icro_Meattini

#LeadArticle 📚 Randomized trials have not yet demonstrated whether topical therapies can prevent the progression of CINII+ in women with a high-risk #HPVinfection @RParejaGineOnco 🔍 bit.ly/4cacbo6 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

🎙️ New #IJGCconversations Topical treatments for HPV: fact or flawed science? 🤔 🎧🌍 Tune in as Dr Rene Pareja breaks down the evidence, challenges common misconceptions, and highlights what truly matters in HPV management. ✨ 🎙️ bit.ly/4vclRqR @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 #WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

How close are we to eliminating cervical cancer? This map represents countries with publicly available national cervical cancer elimination strategies — a critical step from commitment to action. Progress is happening. But gaps remain. Through the International Gynecologic Cancer Society (IGCS) ACCESS initiative and our partnership with the International Cancer Control Partnership (ICCP), we are working to track this progress globally and support countries in moving from planning to implementation. 🌍 Does your country have a plan? 📍 Is it publicly available? 🤝 What support is needed to move forward? Explore the map, access recommended reading, and learn how you can contribute: igcs.org/access #CervicalCancerElimination #GlobalHealth #CancerControl #PublicHealth

Don’t miss the first episode of #SurgicalSpotlight 🎥✨ featuring Susanna Delfrati and Reitan Ribeiro @reitanribeiro, as they share expert surgical insights for the #gynonc community 💜 🎥 bit.ly/48rOHtm @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

Up to date overview of #SLN in ovarian cancer! Thanks @nagustiga and all team for the great work! 🤩 @IJGCfellows @ESGO_society @ENYGO_official @IGCSociety

#2026SpecialIssue Challenging the standard in early-stage #ovariancancer: current evidence and a standardized framework for sentinel node mapping 🔍 bit.ly/4cjZpEH @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

Mark your calendars for the April IJGC journal club! 📆 Rene Pareja will discuss his lead article, a systematic review on the efficacy of topical treatments for high-risk HPV in preventing CIN II+ lesions 🙌 Read the paper 👉 …l-journal-of-gynecological-cancer.com/article/S1048-… Join the club 👉esgo.org/zoom-journal-c… @ijgconline

#Portec4A Shaping the future of #EndometrialCancer care with molecular profiling 🧬 This #IJGCconversations episode is a must-listen for anyone involved in #gynonc! 🎧 bit.ly/4c3qV8f @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88

Share your expertise with a global audience 🎥🌍 Submit your surgical film to the IGCS Education360 Surgical Film Library for expert review and help educate surgeons across regions. With 200+ films and growing, this platform connects global expertise to real-world surgical learning. Submit here: igcs.org/surgical-film-… #IGCSEducation360 #SurgicalFilmLibrary #GlobalSurgery #GynecologicOncology

Join us April 14 for a webinar on the new ESGO Cervical Cancer Resource-Stratified Guidelines, which provide alternative management strategies for situations when optimal resources are unavailable or limited. 📣 Chair: David Cibula 🇨🇿 & speakers Remi Nout 🇳🇱, Anisa Mburu 🇰🇪, & Basel Refky🇪🇬 Register👉 eacademy.esgo.org #gynonc

Minimally invasive surgery in advanced ovarian cancer—are we ready to shift paradigms? 🔹 ↓ blood loss & complications 🔹 Faster recovery 🔹 Careful patient selection is key 🔹 Tech + AI shaping the future 📊 Evidence evolving - RCTs awaited 🔗 bit.ly/4bSG63M @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

De-escalation in Stage IC epithelial ovarian cancer—can we safely do less? 🤔 🔬 Histology-driven decisions 🟢 Safe omission possible in select subtypes ⚖️ Balance survival benefit vs toxicity 🤝 Shared decision-making is essential Not all Stage IC needs chemo — precision matters. 🔗 bit.ly/4m5MdGY @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88 #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

Connect, learn, and save. IGCS members receive discounted registration to the Annual Global Meeting—bringing together the global gynecologic oncology community for a world-class scientific program and meaningful collaboration. 🔗 Learn more: igcs.org/membership #IGCS #MemberBenefits #GlobalMeeting #GynecologicOncology #MedicalEducation #WomenInMedicine #GlobalHealth